From: Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
Haplotype
CR (n, %)
NR (n, %)
χ2
p
OR (95% CI)
AGC
188 (50.9%)
102 (56.6%)
2.871
0.090
0.803 (0.623–1.035)
GAC
127 (34.3%)
62 (34.5%)
0.000
0.998
1.000 (0.767–1.303)
GGT
51 (13.9%)
16 (8.4%)
6.679
0.010
1.738 (1.138–2.652)